In addition, aberrant activation of the Mitogen-Activated Protein Kinase (MAPK) and PI3K/Protein kinase B (AKT)/mTOR pathways is closely linked to HCC progression. The gene discussed is AKT1; the disease is hepatocellular carcinoma.